Skip to main content
SpringerLink
Log in

PET in Thyroid Cancer

  • Chapter
PET/CT

  • 1273 Accesses

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
eBook
USD 16.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. What are the key statistics for thyroid cancer? American Cancer Society (www.cancer.org); 2005 Accessed February 2005.

    Google Scholar 

  2. Greene FL, Page DL, Fleming ID, et al. AJCC Cancer Staging Manual, sixth edition. New York: Springer-Verlag; 2002.

    Google Scholar 

  3. Mackenzie EJ, Mortimer RH. 6: Thyroid nodules and thyroid cancer. Med J Aust 2004;180(5):242–247.

    PubMed  Google Scholar 

  4. Baloch ZW, LiVolsi VA. Fine-needle aspiration of thyroid nodules: past, present, and future. Endocr Pract 2004;10(3):234–241.

    PubMed  Google Scholar 

  5. Kim CE, Joyce JM, Patel N, Lichter J. Fortuitous detection of papillary carcinoma of the thyroid with 18F FDG positron emission tomography in a patient with non-Hodgkin lymphoma. Clin Nucl Med 2003;28(9):782–783.

    Article  PubMed  Google Scholar 

  6. Kresnik E, Gallowitsch HJ, Mikosch P, et al. Fluorine-18-fluorodeoxyglucose positron emission tomography in the preoperative assessment of thyroid nodules in an endemic goiter area. Surgery 2003;133(3):294–299.

    Article  PubMed  Google Scholar 

  7. Ramos CD, Chisin R, Yeung HW, Larson SM, Macapinlac HA. Incidental focal thyroid uptake on FDG positron emission tomographic scans may represent a second primary tumor. Clin Nucl Med 2001;26(3):193–197.

    Article  PubMed  CAS  Google Scholar 

  8. Schoder H, Yeung HW. Positron emission imaging of head and neck cancer, including thyroid carcinoma. Semin Nucl Med 2004;34(3):180–197.

    Article  PubMed  Google Scholar 

  9. Van den Bruel A, Maes A, De Potter T, et al. Clinical relevance of thyroid fluorodeoxyglucose-whole body positron emission tomography incidentaloma. J Clin Endocrinol Metab 2002;87(4):1517–1520.

    Article  PubMed  Google Scholar 

  10. Fernandes JK, Day TA, Richardson MS, Sharma AK. Overview of the management of differentiated thyroid cancer. Curr Treat Options Oncol 2005;6(1):47–57.

    PubMed  Google Scholar 

  11. Sarkar SD, Savitch I. Management of thyroid cancer. Appl Radiol 2004; November: 34–45.

    Google Scholar 

  12. Medicare Coverage Homepage: Centers for Medicare and Medicaid Services (www.cms.hhs.gov/coverage/); 2004 Accessed December 2004.

    Google Scholar 

  13. de Groot JW, Links TP, Jager PL, Kahraman T, Plukker JT. Impact of 18F-fluoro-2-deoxy-D-glucose positron emission tomography (FDG-PET) in patients with biochemical evidence of recurrent or residual medullary thyroid cancer. Ann Surg Oncol 2004;11(8):786–794.

    Article  PubMed  Google Scholar 

  14. Bockisch A, Brandt-Mainz K, Gorges R, Muller S, Stattaus J, Antoch G. Diagnosis in medullary thyroid cancer with [18F]FDG-PET and improvement using a combined PET/CT scanner. Acta Med Austriaca 2003;30(1):22–25.

    Article  PubMed  CAS  Google Scholar 

  15. Diehl M, Risse JH, Brandt-Mainz K, et al. Fluorine-18 fluorodeoxyglucose positron emission tomography in medullary thyroid cancer: results of a multicentre study. Eur J Nucl Med 2001;28(11):1671–1676.

    Article  PubMed  CAS  Google Scholar 

  16. Szakall S, Jr., Esik O, Bajzik G, et al. 18F-FDG PET detection of lymph node metastases in medullary thyroid carcinoma. J Nucl Med 2002;43(1):66–71.

    PubMed  Google Scholar 

  17. Brandt-Mainz K, Muller SP, Gorges R, Saller B, Bockisch A. The value of fluorine-18 fluorodeoxyglucose PET in patients with medullary thyroid cancer. Eur J Nucl Med 2000;27(5):490–496.

    Article  PubMed  CAS  Google Scholar 

  18. Gotthardt M, Battmann A, Hoffken H, et al. 18F-FDG PET, somatostatin receptor scintigraphy, and CT in metastatic medullary thyroid carcinoma: a clinical study and an analysis of the literature. Nucl Med Commun 2004;25(5):439–443.

    Article  PubMed  CAS  Google Scholar 

  19. Rufini V, Salvatori M, Garganese MC, Di Giuda D, Lodovica Maussier M, Troncone L. Role of nuclear medicine in the diagnosis and therapy of medullary thyroid carcinoma. Rays 2000;25(2):273–282.

    PubMed  CAS  Google Scholar 

  20. Hoegerle S, Altehoefer C, Ghanem N, Brink I, Moser E, Nitzsche E. 18F-DOPA positron emission tomography for tumour detection in patients with medullary thyroid carcinoma and elevated calcitonin levels. Eur J Nucl Med 2001;28(1):64–71.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Radiology, Medical University of South Carolina, Charleston, SC, USA

    Ronald B. Workman Jr. MD (Resident)

  2. Duke University Medical Center, Durham, NC, USA

    R. Edward Coleman MD (Professor and Department of Radiology, Director of Nuclear Medicine)

Authors
  1. Ronald B. Workman Jr. MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. R. Edward Coleman MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Department of Radiology, Medical University of South Carolina, Charleston, SC, USA

    Ronald B. Workman Jr. MD (Resident) (Resident)

  2. Duke University Medical Center, Durham, NC, USA

    R. Edward Coleman MD (Professor Department of Radiology and Director of Nuclear Medicine) (Professor Department of Radiology and Director of Nuclear Medicine)

Rights and permissions

Reprints and permissions

Copyright information

© 2006 Springer Science+Business Media, LLC

About this chapter

Cite this chapter

Workman, R.B., Coleman, R.E. (2006). PET in Thyroid Cancer. In: Workman, R.B., Coleman, R.E. (eds) PET/CT. Springer, New York, NY . https://doi.org/10.1007/978-0-387-38335-4_10

Download citation

  • DOI: https://doi.org/10.1007/978-0-387-38335-4_10

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-0-387-32166-0

  • Online ISBN: 978-0-387-38335-4

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation